✦ LIBER ✦

Danazol in the treatment of GI hemorrhage secondary to hereditary hemorrhagic telangiectasia

✍ Scribed by Korzenik, Joshua R.; Topazian, Mark; Burdge, Catherine; White, Robert I.

Book ID: 123059550
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 174 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)23849-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in the treatment of heredita

Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia

✍ Kanellopoulou, Theoni; Alexopoulou, Alexandra 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 360 KB

Hereditary hemorrhagic telangiectasia in

Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations

✍ T. Krings; S.M. Chng; A. Ozanne; H. Alvarez; G. Rodesch; P.L. Lasjaunias 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 406 KB

Efficiency of laser treatment in patient

Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia

✍ Gita Jørgensen; Bibi Lange; Jens Højberg Wanscher; Anette Drøhse Kjeldsen 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 300 KB

Topical timolol for the treatment of epi

Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia

✍ Scott E. Olitsky 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Nd:YAG laser in the treatment of epistax

Nd:YAG laser in the treatment of epistaxis in hereditary hemorrhagic telangiectasia

✍ Hassan H. Ramadan 📂 Article 📅 1996 🏛 SAGE Publications 🌐 English ⚖ 210 KB

The effect of bevacizumab (Avastin) trea

The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia

✍ Jana Simonds; Frank Miller; Jess Mandel; Terence M. Davidson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract ## Objectives/Hypothesis: Determine the effectiveness of treating epistaxis in hereditary hemorrhagic telangiectasia (HHT) with potassium titanyl phosphate (KTP) laser cautery combined with submucosal injection of 100 mg of bevacizumab. ## Study Design: Retrospective pilot study. ##